scholarly journals Impact of sex difference on survival of bladder cancer: A population‐based registry data in Japan

2019 ◽  
Vol 26 (6) ◽  
pp. 649-654 ◽  
Author(s):  
Masashi Nakayama ◽  
Yuri Ito ◽  
Koji Hatano ◽  
Yasutomo Nakai ◽  
Ken‐ichi Kakimoto ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Sex Difference ◽  
Population Based ◽  
Registry Data ◽  
Population Based Registry

The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data

2020 ◽  
Author(s):  
Gorica D. Maric ◽  
Tatjana D. Pekmezovic ◽  
Sarlota T. Mesaros ◽  
Olivera S. Tamas ◽  
Jovana B. Ivanovic ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Population Based ◽  
Registry Data ◽  
Multiple Sclerosis Population ◽  
Population Based Registry

Increasing incidence and more active therapy of patients with bladder cancer in Sweden: A population based registry study

2018 ◽  
Vol 17 (2) ◽  
pp. e1059
Author(s):  
T. Gårdmark ◽  
S. Jahnson ◽  
V. Ströck ◽  
F. Aljabery ◽  
A.A. Hosseini ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Population Based ◽  
Registry Study ◽  
Active Therapy ◽  
Population Based Registry

Quality Improvement to Immunization Coverage in Primary Care Measured in Medical Record and Population-Based Registry Data

2018 ◽  
Vol 18 (4) ◽  
pp. 437-444 ◽  
Author(s):  
Valerie S. Harder ◽  
Sara E. Barry ◽  
Bridget Ahrens ◽  
Wendy S. Davis ◽  
Judith S. Shaw
Keyword(s):  
Primary Care ◽  
Quality Improvement ◽  
Medical Record ◽  
Immunization Coverage ◽  
Population Based ◽  
Registry Data ◽  
Population Based Registry

scholarly journals Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data

BMJ ◽  
2011 ◽  
Vol 343 (nov23 1) ◽  
pp. d7017-d7017 ◽  
Author(s):  
A. Seigneurin ◽  
O. Francois ◽  
J. Labarere ◽  
P. Oudeville ◽  
J. Monlong ◽  
...  
Keyword(s):  
Stochastic Simulation ◽  
Simulation Study ◽  
Population Based ◽  
Screening Mammography ◽  
Registry Data ◽  
Population Based Registry

Impact of including second and later cancers in cause‐specific survival estimates using population‐based registry data

Cancer ◽  
2021 ◽  
Author(s):  
Gonçalo Forjaz ◽  
Nadia Howlader ◽  
Steve Scoppa ◽  
Christopher J. Johnson ◽  
Angela B. Mariotto
Keyword(s):  
Population Based ◽  
Registry Data ◽  
Population Based Registry ◽  
Cause Specific Survival

scholarly journals Long‐term trends in sex difference in bladder cancer survival 1975‐2009: A population‐based study in Osaka, Japan

2020 ◽  
Vol 9 (19) ◽  
pp. 7330-7340
Author(s):  
Jo Aoe ◽  
Yuri Ito ◽  
Keisuke Fukui ◽  
Masashi Nakayama ◽  
Toshitaka Morishima ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Sex Difference ◽  
Cancer Survival ◽  
Population Based ◽  
Population Based Study ◽  
Long Term Trends

scholarly journals The Impact of Multiple Malignancies on Patients with Bladder Carcinoma: A Population-Based Study Using the SEER Database

2009 ◽  
Vol 2009 ◽  
pp. 1-7 ◽  
Author(s):  
Joshua R. Ehrlich ◽  
Michael J. Schwartz ◽  
Casey K. Ng ◽  
Eric C. Kauffman ◽  
Douglas S. Scherr
Keyword(s):  
Bladder Cancer ◽  
Cancer Patients ◽  
Population Based ◽  
Survival Advantage ◽  
Future Research ◽  
Population Based Study ◽  
Multiple Malignancies ◽  
High Stage ◽  
Population Based Registry ◽  
The Impact

Purpose. To date, no study has examined a population-based registry to determine the impact of multiple malignancies on survival of bladder cancer patients. Our experience suggests that bladder cancer patients with multiple malignancies may have relatively positive outcomes.Materials & Methods. We utilized data from the Surveillance Epidemiology and End Results (SEERs) database to examine survival between patients with only bladder cancer (BO) and with bladder cancer and additional cancer(s) antecedent (AB), subsequent (BS), or antecedent and subsequent to bladder cancer (ABS).Results. Analyses demonstrated diminished survival among AB and ABS cohorts. However, when cohorts were substratified by stage, patients in the high-stage BS cohort appeared to have a survival advantage over high-stage BO patients.Conclusions. Bladder cancer patients with multiple malignancies have diminished survival. The survival advantage of high-stage BS patients is likely a statistical phenomenon. Such findings are important to shape future research and to improve our understanding of patients with multiple malignancies.

Sign in / Sign up

Export Citation Format

Share Document